Drugs with a negative impact on cognitive function (Part 1) : chronic kidney disease as a risk factor
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA..
People living with chronic kidney disease (CKD) frequently suffer from mild cognitive impairment and/or other neurocognitive disorders. This review in two parts will focus on adverse drug reactions resulting in cognitive impairment as a potentially modifiable risk factor in CKD patients. Many patients with CKD have a substantial burden of comorbidities leading to polypharmacy. A recent study found that patients seen by nephrologists were the most complex to treat because of their high number of comorbidities and medications. Due to polypharmacy, these patients may experience a wide range of adverse drug reactions. Along with CKD progression, the accumulation of uremic toxins may lead to blood-brain barrier (BBB) disruption and pharmacokinetic alterations, increasing the risk of adverse reactions affecting the central nervous system (CNS). In patients on dialysis, the excretion of drugs that depend on kidney function is severely reduced such that adverse and toxic levels of a drug or its metabolites may be reached at relatively low doses, unless dosing is adjusted. This first review will discuss how CKD represents a risk factor for adverse drug reactions affecting the CNS via (i) BBB disruption associated with CKD and (ii) the impact of reduced kidney function and dialysis itself on drug pharmacokinetics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Clinical kidney journal - 16(2023), 12 vom: 01. Dez., Seite 2365-2377 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liabeuf, Sophie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse drug reactions |
|---|
| Anmerkungen: |
Date Revised 05.12.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/ckj/sfad241 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365369713 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365369713 | ||
| 003 | DE-627 | ||
| 005 | 20231226101523.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ckj/sfad241 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1217.xml |
| 035 | |a (DE-627)NLM365369713 | ||
| 035 | |a (NLM)38045996 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liabeuf, Sophie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drugs with a negative impact on cognitive function (Part 1) |b chronic kidney disease as a risk factor |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.12.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. | ||
| 520 | |a People living with chronic kidney disease (CKD) frequently suffer from mild cognitive impairment and/or other neurocognitive disorders. This review in two parts will focus on adverse drug reactions resulting in cognitive impairment as a potentially modifiable risk factor in CKD patients. Many patients with CKD have a substantial burden of comorbidities leading to polypharmacy. A recent study found that patients seen by nephrologists were the most complex to treat because of their high number of comorbidities and medications. Due to polypharmacy, these patients may experience a wide range of adverse drug reactions. Along with CKD progression, the accumulation of uremic toxins may lead to blood-brain barrier (BBB) disruption and pharmacokinetic alterations, increasing the risk of adverse reactions affecting the central nervous system (CNS). In patients on dialysis, the excretion of drugs that depend on kidney function is severely reduced such that adverse and toxic levels of a drug or its metabolites may be reached at relatively low doses, unless dosing is adjusted. This first review will discuss how CKD represents a risk factor for adverse drug reactions affecting the CNS via (i) BBB disruption associated with CKD and (ii) the impact of reduced kidney function and dialysis itself on drug pharmacokinetics | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a adverse drug reactions | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a cognitive impairment | |
| 650 | 4 | |a drug prescription | |
| 700 | 1 | |a Pešić, Vesna |e verfasserin |4 aut | |
| 700 | 1 | |a Spasovski, Goce |e verfasserin |4 aut | |
| 700 | 1 | |a Maciulaitis, Romaldas |e verfasserin |4 aut | |
| 700 | 1 | |a Bobot, Mickaël |e verfasserin |4 aut | |
| 700 | 1 | |a Farinha, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Wagner, Carsten A |e verfasserin |4 aut | |
| 700 | 1 | |a Unwin, Robert J |e verfasserin |4 aut | |
| 700 | 1 | |a Capasso, Giovambattista |e verfasserin |4 aut | |
| 700 | 1 | |a Bumblyte, Inga Arune |e verfasserin |4 aut | |
| 700 | 1 | |a Hafez, Gaye |e verfasserin |4 aut | |
| 700 | 0 | |a CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) |e verfasserin |4 aut | |
| 700 | 1 | |a Capasso, Giovambattista |e investigator |4 oth | |
| 700 | 1 | |a Andrade, Alexandre |e investigator |4 oth | |
| 700 | 1 | |a Bachmann, Maie |e investigator |4 oth | |
| 700 | 1 | |a Bumblyte, Inga |e investigator |4 oth | |
| 700 | 1 | |a Covic, Adrian Constantin |e investigator |4 oth | |
| 700 | 1 | |a Delgado, Pilar |e investigator |4 oth | |
| 700 | 1 | |a Endlich, Nicole |e investigator |4 oth | |
| 700 | 1 | |a Engvig, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Fouque, Denis |e investigator |4 oth | |
| 700 | 1 | |a Franssen, Casper |e investigator |4 oth | |
| 700 | 1 | |a Frische, Sebastian |e investigator |4 oth | |
| 700 | 1 | |a Garneata, Liliana |e investigator |4 oth | |
| 700 | 1 | |a Gesualdo, Loreto |e investigator |4 oth | |
| 700 | 1 | |a Giannakou, Konstantinos |e investigator |4 oth | |
| 700 | 1 | |a Goumenos, Dimitrios |e investigator |4 oth | |
| 700 | 1 | |a Kartal, Ayşe Tuğba |e investigator |4 oth | |
| 700 | 1 | |a Liabeuf, Sophie |e investigator |4 oth | |
| 700 | 1 | |a Mani, Laila-Yasmin |e investigator |4 oth | |
| 700 | 1 | |a Marti, Hans-Peter |e investigator |4 oth | |
| 700 | 1 | |a Mayer, Christopher |e investigator |4 oth | |
| 700 | 1 | |a Nielsen, Rikke |e investigator |4 oth | |
| 700 | 1 | |a Pešić, Vesna |e investigator |4 oth | |
| 700 | 1 | |a Rroji Molla, Merita |e investigator |4 oth | |
| 700 | 1 | |a Sakkas, Giorgos |e investigator |4 oth | |
| 700 | 1 | |a Spasovski, Goce |e investigator |4 oth | |
| 700 | 1 | |a Stevens, Kate |e investigator |4 oth | |
| 700 | 1 | |a Vazelov, Evgueniy |e investigator |4 oth | |
| 700 | 1 | |a Viggiano, Davide |e investigator |4 oth | |
| 700 | 1 | |a Zacharia, Lefteris |e investigator |4 oth | |
| 700 | 1 | |a Ferreira, Ana Carina |e investigator |4 oth | |
| 700 | 1 | |a Malyszko, Jolanta |e investigator |4 oth | |
| 700 | 1 | |a Hoorn, Ewout |e investigator |4 oth | |
| 700 | 1 | |a Figurek, Andreja |e investigator |4 oth | |
| 700 | 1 | |a Unwin, Robert |e investigator |4 oth | |
| 700 | 1 | |a Wagner, Carsten |e investigator |4 oth | |
| 700 | 1 | |a Wanner, Christoph |e investigator |4 oth | |
| 700 | 1 | |a Bruchfeld, Annette |e investigator |4 oth | |
| 700 | 1 | |a Pepin, Marion |e investigator |4 oth | |
| 700 | 1 | |a Wiecek, Andrzej |e investigator |4 oth | |
| 700 | 1 | |a Nitsch, Dorothea |e investigator |4 oth | |
| 700 | 1 | |a Fridolin, Ivo |e investigator |4 oth | |
| 700 | 1 | |a Hafez, Gaye |e investigator |4 oth | |
| 700 | 1 | |a Romeo, Maria José Soler |e investigator |4 oth | |
| 700 | 1 | |a Barbieri, Michelangela |e investigator |4 oth | |
| 700 | 1 | |a Batinić, Bojan |e investigator |4 oth | |
| 700 | 1 | |a Carrasco, Laura |e investigator |4 oth | |
| 700 | 1 | |a Carriazo, Sol |e investigator |4 oth | |
| 700 | 1 | |a Gansevoort, Ron |e investigator |4 oth | |
| 700 | 1 | |a Martino, Gianvito |e investigator |4 oth | |
| 700 | 1 | |a Raso, Francesco Mattace |e investigator |4 oth | |
| 700 | 1 | |a Nistor, Ionut |e investigator |4 oth | |
| 700 | 1 | |a Ortiz, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Paolisso, Giuseppe |e investigator |4 oth | |
| 700 | 1 | |a Rastenytė, Daiva |e investigator |4 oth | |
| 700 | 1 | |a Stefan, Gabriel |e investigator |4 oth | |
| 700 | 1 | |a Tedeschi, Gioacchino |e investigator |4 oth | |
| 700 | 1 | |a Massy, Ziad |e investigator |4 oth | |
| 700 | 1 | |a Bikbov, Boris |e investigator |4 oth | |
| 700 | 1 | |a Endlich, Karl Hans |e investigator |4 oth | |
| 700 | 1 | |a Godefroy, Olivier |e investigator |4 oth | |
| 700 | 1 | |a Kossioni, Anastassia |e investigator |4 oth | |
| 700 | 1 | |a Kurganaite, Justina |e investigator |4 oth | |
| 700 | 1 | |a Perico, Norberto |e investigator |4 oth | |
| 700 | 1 | |a Remuzzi, Giuseppe |e investigator |4 oth | |
| 700 | 1 | |a Grodzicki, Tomasz |e investigator |4 oth | |
| 700 | 1 | |a Trepiccione, Francesco |e investigator |4 oth | |
| 700 | 1 | |a Zoccali, Carmine |e investigator |4 oth | |
| 700 | 1 | |a Arici, Mustafa |e investigator |4 oth | |
| 700 | 1 | |a Blankestijn, Peter |e investigator |4 oth | |
| 700 | 1 | |a Eckardt, Kai-Uwe |e investigator |4 oth | |
| 700 | 1 | |a Fliser, Danilo |e investigator |4 oth | |
| 700 | 1 | |a Jiménez, Eugenio Gutiérrez |e investigator |4 oth | |
| 700 | 1 | |a Konig, Maximilian |e investigator |4 oth | |
| 700 | 1 | |a Rychlik, Ivan |e investigator |4 oth | |
| 700 | 1 | |a Deleidi, Michela |e investigator |4 oth | |
| 700 | 1 | |a Reusz, George |e investigator |4 oth | |
| 700 | 1 | |a Farisco, Michele |e investigator |4 oth | |
| 700 | 1 | |a Perico, Norberto |e investigator |4 oth | |
| 700 | 1 | |a Silva, Pedro Imenez |e investigator |4 oth | |
| 700 | 1 | |a Bobot, Mickaël |e investigator |4 oth | |
| 700 | 1 | |a Golenia, Aleksandra |e investigator |4 oth | |
| 700 | 1 | |a Perna, Alessandra |e investigator |4 oth | |
| 700 | 1 | |a Idrizi, Alma |e investigator |4 oth | |
| 700 | 1 | |a Hansen, Brian |e investigator |4 oth | |
| 700 | 1 | |a Simeoni, Mariadelina |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical kidney journal |d 2012 |g 16(2023), 12 vom: 01. Dez., Seite 2365-2377 |w (DE-627)NLM219739579 |x 2048-8505 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:12 |g day:01 |g month:12 |g pages:2365-2377 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ckj/sfad241 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 12 |b 01 |c 12 |h 2365-2377 | ||